Quick Answer
Quoin Pharmaceuticals, Ltd. reported R&D Expense of $9.80 million for fiscal year 2025.
Quoin Pharmaceuticals, Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.80M | +172.1% |
| 2024 | $3.60M | +8.9% |
| 2023 | $3.31M | +23.8% |
| 2022 | $2.67M | +71.0% |
| 2021 | $1.56M | +540.1% |
| 2020 | $244.2K | +434.8% |
| 2019 | $45.6K | -99.7% |
| 2018 | $13.51M | +217.5% |
| 2017 | -$11.50M | -239.3% |
| 2016 | $8.26M | +40.1% |
| 2015 | $5.89M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.28M | +111.3% | +11.2% |
| June 30, 2025 | $2.05M | +249.0% | -13.6% |
| March 31, 2025 | $2.37M | +168.2% | +119.9% |
| September 30, 2024 | $1.08M | +42.3% | +83.8% |
| June 30, 2024 | $587.5K | -6.0% | -33.6% |
| March 31, 2024 | $885.3K | -18.9% | +16.7% |
| September 30, 2023 | $758.8K | +1.8% | +21.4% |
| June 30, 2023 | $625.1K | -14.0% | -42.7% |
- Quoin Pharmaceuticals, Ltd. showed an increase of +172.1% in R&D Expense compared to the prior fiscal year.
- Over the 2015–2025 period, Quoin Pharmaceuticals, Ltd.’s r&d expense has grown by 66.3% (from $5.89 million to $9.80 million).
- The most recent figure is from Quoin Pharmaceuticals, Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: